Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration
Jing Jin, Qijie Zhao
Theranostics (2020) Vol. 10, Iss. 14, pp. 6231-6244
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment
Sahar Mafi, Behzad Mansoori, Shahram Taeb, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 130
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
Feng Li, Yuqiao Sheng, Weizhou Hou, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000131-e000131
Open Access | Times Cited: 86
Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors
Roman V. Uzhachenko, Vijaya Bharti, Zhufeng Ouyang, et al.
Cell Reports (2021) Vol. 35, Iss. 1, pp. 108944-108944
Open Access | Times Cited: 73
Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment
Rongyang Li, Bing Huang, Hui Tian, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 22
How can we turn the PI3K/AKT/mTOR pathway down? Insights into inhibition and treatment of cancer
Said M. Afify, Aung Ko Ko Oo, Ghmkin Hassan, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 6, pp. 605-619
Closed Access | Times Cited: 29
mTOR activity is essential for retinal pigment epithelium regeneration in zebrafish
Fangfang Lu, Lyndsay L. Leach, Jeffrey M. Gross
PLoS Genetics (2022) Vol. 18, Iss. 3, pp. e1009628-e1009628
Open Access | Times Cited: 20
IL-1β-activated mTORC2 promotes accumulation of IFN-γ+ γδ T cells by upregulating CXCR3 to restrict hepatic fibrosis
Qihui Liu, Quanli Yang, Zengfeng Wu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 20
Theranostic Rhenium Complexes as Suborganelle-Targeted Copper Ionophores To Stimulate Cuproptosis for Cancer Immunotherapy
Yu‐Yi Ling, Qing‐Hua Shen, Hao Liang, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
CHMP2A regulates broad immune cell-mediated antitumor activity in an immunocompetent in vivo head and neck squamous cell carcinoma model
Jiyoung Yun, Robert Saddawi‐Konefka, Benjamin Goldenson, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 5, pp. e007187-e007187
Open Access | Times Cited: 3
Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression
敬 島津, Yi Li, Qijie Zhao, et al.
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 22
Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment
Shilpi Singh, Debashis Barik, Karl Lawrie, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14960-14960
Open Access | Times Cited: 8
Chemically engineered mTOR-nanoparticle blockers enhance antitumour efficacy
Hong Tang, Dilinuer Dilimulati, Zhentao Yang, et al.
EBioMedicine (2024) Vol. 103, pp. 105099-105099
Open Access | Times Cited: 2
A Biomimetic Targeted Nanosystem Delivering Synergistic Inhibitors for Glioblastoma Immune Microenvironment Reprogramming and Treatment
Yulei Mu, Zhen Zhang, Huiqun Zhou, et al.
Materials Today Bio (2024) Vol. 28, pp. 101222-101222
Open Access | Times Cited: 2
Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer
Curtis A. Clark, Eddy S. Yang
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 16
Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications
Shailendra Kumar Maurya, Parvez Κhan, Asad Ur Rehman, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 914-930
Open Access | Times Cited: 16
Molecular pathways enhance drug response prediction using transfer learning from cell lines to tumors and patient-derived xenografts
Yi-Ching Tang, Reid T. Powell, Assaf Gottlieb
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Role of different immune cells and metabolic pathways in modulating the immune response in pancreatic cancer (Review)
Nnenna Elebo, Pascaline Fonteh, J. Omoshoro–Jones, et al.
Molecular Medicine Reports (2020) Vol. 22, Iss. 6, pp. 4981-4991
Open Access | Times Cited: 14
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma
Jan-Malte Placke, Jenny Bottek, Renáta Váraljai, et al.
British Journal of Dermatology (2024)
Closed Access | Times Cited: 1
Investigation on the regulatory T cells signature and relevant Foxp3/STAT3 axis in esophageal cancer
Lin Yang, Qijie Zhao, Xing Wang, et al.
Cancer Medicine (2022) Vol. 12, Iss. 4, pp. 4993-5008
Open Access | Times Cited: 7
Myeloid-derived suppressor cells: Emerging players in cancer and beyond
Carlos Jiménez‐Cortegana, Lorenzo Galluzzi
International review of cell and molecular biology (2023), pp. xiii-xix
Closed Access | Times Cited: 3
Basic approaches, challenges and opportunities for the discovery of small molecule anti-tumor drugs.
Yu‐Shui Ma, Ji‐Bin Liu, Xiao‐Li Yang, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 6, pp. 2386-2400
Closed Access | Times Cited: 4
Identification of Gene-Set Signature in Early-Stage Hepatocellular Carcinoma and Relevant Immune Characteristics
Qijie Zhao, Rawiwan Wongpoomchai, Arpamas Chariyakornkul, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 4
The m-TORC1 inhibitor Sirolimus increases the effectiveness of Photodynamic therapy in the treatment of cutaneous Squamous Cell Carcinoma, impairing NRF2 antioxidant signaling
Jimena Nicolás-Morala, Marta Mascaraque, María Gallego-Rentero, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 11, pp. 4238-4257
Open Access
scHyper: reconstructing cell–cell communication through hypergraph neural networks
Wenying Li, Haiyun Wang, Jianping Zhao, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 5
Open Access
Decoding mTOR signalling heterogeneity in the tumour microenvironment using multiplexed imaging and graph convolutional networks
Razan Zuhair, Mark Eastwood, Megan M. Jones, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top